-
-
-
-
-
-
-
Soleno Therapeutics, Inc. (SLNO) Tops Q3 EPS by 42c
-
-
-
-
-
-
-
Soleno Therapeutics reports preliminary Q2 revenue of $31-33 million
-
-
-
-
-
-
-
Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
-
-
-
-
-
-
-
Soleno Therapeutics, Inc. (SLNO) Misses Q4 EPS by 6c
-
-
-
-
-
-
-
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
-
-
-
-
-
-
-
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
-
-
-
-
-
-
-
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

